Medication management Archive

Diagnosing hypothyroidism can be tricky because typical symptoms (such as fatigue and trouble losing weight) have many other possible causes. Some people treated for hypothyroidism may be able to safely stop treatment with close medical monitoring.

Cardiac amyloidosis is a rare heart condition that causes the walls of the heart to become thick, stiff, and unable to pump normally. Three FDA-approved medications for the most common form, ATTR-CM, slow disease progression and extend life.

People who have a low coronary artery calcium score (between 1 and 99) have signs of early heart disease. Current guidelines recommend taking a statin, with a goal of lowering LDL cholesterol by at least 30%.

Gout is a form of arthritis caused by too much uric acid, which leaves the bloodstream and settles in joints. Uric acid crystals can form in joints, causing redness, swelling and pain—a gout flare. Drugs taken over a long term can lower uric acid levels and prevent flares.

Taking antiplatelet drugs can make any “blood thinner” advice confusing. Which blood-thinning medications vitamin K affects matters here.

In late 2025, the FDA approved a nasal spray to treat a sporadic, rapid heart rhythm called paroxysmal supraventricular tachycardia (PSVT). The self-administered spray, called etripamil (Cardamyst), may help people avoid emergency room treatment for PSVT.

Social media posts tend to exaggerate side effects (such as muscle aches and memory problems) associated with statins and may spread invalid information about these drugs. This misinformation is a major threat to public health, according to a 2025 article.

After an FDA panel was convened to review black box warnings on menopause hormone therapy, which includes both systemic and vaginal estrogen treatments, the FDA announced in November 2025 it would remove black box warnings from all hormone therapy products containing estrogen. Women considering hormone therapy should discuss their individual health risks with their doctor - such as a history of heart attack or stroke, a blood clot in the legs or lungs, hormone-sensitive cancer, active liver disease, and overall breast cancer and cardiovascular risks.